Drug Trial News

RSS

Obesity and weight gain are associated with increased risk for developing kidney stones

Kidney stones are a major cause of illness, according to background information in the article. The lifetime prevalence of kidney stones is approximately 10 percent in men and 5 percent in women, and more than $2 billion is spent on treatment each year.

26 Jan 2005

Drug reviparin reduces the risk of death after heart attack

The drug reviparin (a low molecular weight heparin anticoagulant), when administered to patients with a heart attack, is effective in reducing the risk of death and the risk of a subsequent heart attack, according to a study in the January 26 issue of JAMA.

26 Jan 2005

New method of delivery of gene therapy may lead to safer treatment for cancer

The Lankenau Institute for Medical Research (LIMR) announced that in collaboration with the Massachusetts Institute of Technology (MIT) they have performed preclinical proof-of- principle studies showing how nanotechnology can be used to enhance gene therapy for cancer.

25 Jan 2005

Whole-body computed tomography (CT) is not a cost-effective screening method

The use of whole-body CT as a screening tool for cancer and other diseases is the focus of an ongoing debate. Proponents of whole-body CT emphasize the potential benefit of early detection of disease, but others caution that the costs, false-positive findings and unnecessary radiation might render the procedure more harmful than beneficial.

25 Jan 2005

Blood clots in the lungs could be prevented with computed tomography (CT) scans of the legs

Researchers found that indirect CT venography (CTV) could identify blood clots in the legs that have the potential to break free, travel to the lung and block an artery--a life-threatening condition known as pulmonary embolism.

25 Jan 2005

Sociologists create a love map for an entire high school

For the first time, sociologists have mapped the romantic and sexual relationships of an entire high school over 18 months, providing evidence that these adolescent networks may be structured differently than researchers previously thought.

25 Jan 2005

Younr black people experience the most pain

Adults under the age of 50 who have chronic pain may be less able to cope with their condition and more prone to associated depression than their elders, a new study suggests.

25 Jan 2005

Vioxx could have caused 140000 excess cases of coronary heart disease in the USA since 1999

The arthritis drug Vioxx could have caused an estimated 88 000–140 000 excess cases of serious coronary heart disease in the USA since its launch in 1999, concludes a study published online by The Lancet.

24 Jan 2005

Dietary fat quality may be more important than fat quantity in reducing risk of cardiovascular deaths in middle-aged men

The type of dietary fats consumed by middle-aged men, especially polyunsaturated fats and linoleic acids, may be more important than total fat intake in reducing the risk of cardiovascular deaths, according to a study in the January 24 issue of Archives of Internal Medicine.

24 Jan 2005

Warfarin combined with NSAIDs or COX-2 inhibitors increased risk of upper gastrointentinal hemorrhage

Patients taking warfarin at the same time as selective COX-2 inhibitors or nonselective NSAIDs have an increased risk of hospitalization for upper gastrointestinal (GI) hemorrhage, according to Canadian researchers analyzing health care databases.

24 Jan 2005

Study of patients on COX-2 inhibitors does not show increased cardiovascular risk

An observational study of 6,250 patients enrolled in the Maryland Medicaid program found that COX-2 inhibitors did not increase the risk for cardiovascular events over nonnaproxen NSAIDs in a high-risk population.

24 Jan 2005

More studies on risks and benefits of COX-2 inhibitors

A group of studies published in the January 24 issue of Archives of Internal Medicine add to the growing body of medical literature about the cardiovascular risks that may be associated with the class of pain-relieving drugs known as COX-2 inhibitors.

24 Jan 2005

Living in a disadvantaged neighborhood may increase HIV risk

Living in a disadvantaged urban neighborhood can increase a male residents’ risk of contracting HIV, according to researchers at the Johns Hopkins Bloomberg School of Public Health. Their study related disadvantaged neighborhoods to stress and stress to increased injection drug use in male study participants.

24 Jan 2005

Use of anti-inflammatory steroids for traumatic head injuries may actually increase the risk of death

The common use of anti-inflammatory steroids for traumatic head injuries like those from car crashes may actually increase the risk of death, according to a new review of studies about the treatment.

24 Jan 2005

No association between neuroticism and extroversion – and cancer

There is no association between two specific personality traits – neuroticism and extroversion – and cancer, according to a new study, one of the largest prospective twin studies to examine this issue.

24 Jan 2005

Obesity is linked to lower levels of prostate specific antigen (PSA) in men

A study reported in the current issue of Cancer, the journal of the American Cancer Society, shows that obesity is linked to lower levels of prostate specific antigen (PSA) in men, making early detection tests unreliable.

24 Jan 2005

Are NSAIDS enough for cancer pain?

Non-steroidal anti-inflammatory drugs (NSAIDs) are effective in managing cancer pain with few side effects, according to a new review of a number of studies.

24 Jan 2005

Antioxidants do not prolong the survival of patients with amyotrophic lateral sclerosis, or Lou Gehrig’s disease

A review of recent studies suggests that antioxidant supplements, including vitamin E and selenium, do not prolong the survival of patients with amyotrophic lateral sclerosis, or Lou Gehrig’s disease.

24 Jan 2005

Severity of liver disease not a reliable indicator of quality of life

A new study on the determination of how livers are allocated for transplants examined the relationship between liver disease severity and quality of life, and found that the commonly used model for liver allocation is not a reliable indicator of general quality of life.

24 Jan 2005

Pharmacist review does not keep older people out of hospital

The NHS recommends regular medication reviews for older patients, yet a study published on bmj.com today finds that home based monitoring does not keep older people out of hospital.

20 Jan 2005

Drug Trial News

Obesity and weight gain are associated with increased risk for developing kidney stones

Drug reviparin reduces the risk of death after heart attack

New method of delivery of gene therapy may lead to safer treatment for cancer

Whole-body computed tomography (CT) is not a cost-effective screening method

Blood clots in the lungs could be prevented with computed tomography (CT) scans of the legs

Sociologists create a love map for an entire high school

Younr black people experience the most pain

Vioxx could have caused 140000 excess cases of coronary heart disease in the USA since 1999

Dietary fat quality may be more important than fat quantity in reducing risk of cardiovascular deaths in middle-aged men

Warfarin combined with NSAIDs or COX-2 inhibitors increased risk of upper gastrointentinal hemorrhage

Study of patients on COX-2 inhibitors does not show increased cardiovascular risk

More studies on risks and benefits of COX-2 inhibitors

Living in a disadvantaged neighborhood may increase HIV risk

Use of anti-inflammatory steroids for traumatic head injuries may actually increase the risk of death

No association between neuroticism and extroversion – and cancer

Obesity is linked to lower levels of prostate specific antigen (PSA) in men

Are NSAIDS enough for cancer pain?

Antioxidants do not prolong the survival of patients with amyotrophic lateral sclerosis, or Lou Gehrig’s disease

Severity of liver disease not a reliable indicator of quality of life

Pharmacist review does not keep older people out of hospital

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News